189 related articles for article (PubMed ID: 10390604)
21. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
Gharehbaghi K; Grünberger W; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
Prosise GL; Wu JZ; Luecke H
J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
[TBL] [Abstract][Full Text] [Related]
23. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.
Franchetti P; Cappellacci L; Perlini P; Jayaram HN; Butler A; Schneider BP; Collart FR; Huberman E; Grifantini M
J Med Chem; 1998 May; 41(10):1702-7. PubMed ID: 9572896
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
25. The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides.
Matsuda A; Minakawa N; Sasaki T; Ueda T
Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2730-3. PubMed ID: 3272143
[No Abstract] [Full Text] [Related]
26. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
Yamada Y; Goto H; Yoshino M; Ogasawara N
Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of 5-thiobredinin and certain related 5-substituted imidazole-4-carboxamide ribonucleosides.
Wood SG; Upadhya KG; Dalley NK; McKernan PA; Canonico PG; Robins RK; Revankar GR
J Med Chem; 1985 Sep; 28(9):1198-203. PubMed ID: 2993613
[TBL] [Abstract][Full Text] [Related]
29. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
[TBL] [Abstract][Full Text] [Related]
30. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
[TBL] [Abstract][Full Text] [Related]
31. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
Markham GD; Bock CL; Schalk-Hihi C
Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
[TBL] [Abstract][Full Text] [Related]
32. Dehydrogenase binding by tiazofurin anabolites.
Goldstein BM; Bell JE; Marquez VE
J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
[TBL] [Abstract][Full Text] [Related]
33. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
Yamada Y; Natsumeda Y; Weber G
Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.
Colby TD; Vanderveen K; Strickler MD; Markham GD; Goldstein BM
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3531-6. PubMed ID: 10097070
[TBL] [Abstract][Full Text] [Related]
35. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Balzarini J; De Clercq E
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
[TBL] [Abstract][Full Text] [Related]
36. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
Jayaram HN; Dion RL; Glazer RI; Johns DG; Robins RK; Srivastava PC; Cooney DA
Biochem Pharmacol; 1982 Jul; 31(14):2371-80. PubMed ID: 6127085
[No Abstract] [Full Text] [Related]
37. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P
Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
[TBL] [Abstract][Full Text] [Related]
39. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
40. A new C-nucleoside analogue of tiazofurin: synthesis and biological evaluation of 2-beta-D-ribofuranosylimidazole-4-carboxamide (imidazofurin).
Franchetti P; Marchetti S; Cappellacci L; Yalowitz JA; Jayaram HN; Goldstein BM; Grifantini M
Bioorg Med Chem Lett; 2001 Jan; 11(1):67-9. PubMed ID: 11140736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
